Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Macular Degeneration
NCT05439629
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
488
Enrollment
INDUSTRY
Sponsor class
Conditions
Neovascular (Wet) Age-related Macular Degeneration
Interventions
DRUG:
BAT5906 injection
DRUG:
Lucentis
Sponsor
Bio-Thera Solutions